Hepatitis C often presents without symptoms, especially in the early stages. When symptoms do occur, they may include fatigue, jaundice (yellowing of the skin and eyes), dark urine, abdominal pain, loss of appetite, and nausea. Chronic infection can lead to liver damage, cirrhosis (scarring of the liver), liver failure, or liver cancer over many years. Because symptoms are often absent or non-specific, many people are unaware they are infected until significant liver damage has occurred.

Diagnosing Hepatitis C involves several steps. Initially, a blood test is used to detect antibodies to the virus, indicating exposure. If antibodies are present, a follow-up test is conducted to measure the amount of virus in the blood (viral load) and confirm active infection. Additional tests, such as liver function tests and imaging studies, may be performed to assess liver damage. In some cases, a liver biopsy may be necessary to evaluate the extent of liver injury.

The treatment of Hepatitis C has advanced significantly in recent years. Direct-acting antiviral (DAA) medications are the cornerstone of therapy, offering high cure rates with fewer side effects than older treatments. Treatment duration typically ranges from 8 to 12 weeks, depending on the specific medication regimen and the genotype of the virus. Successful treatment can eliminate the virus from the body, reducing the risk of liver damage and improving overall health outcomes.

The prognosis for individuals with Hepatitis C has improved dramatically with the advent of effective antiviral treatments. Most people who complete treatment achieve a sustained virologic response, meaning the virus is no longer detectable in their blood. This significantly reduces the risk of liver-related complications. However, those with advanced liver disease or cirrhosis may still face ongoing health challenges and require regular monitoring.

Hepatitis C is caused by the Hepatitis C Virus, a small, enveloped RNA virus. It is primarily transmitted through exposure to infected blood. Common routes of transmission include sharing needles or other drug-injection equipment, receiving contaminated blood products (though this is rare in countries with rigorous blood screening), and, less commonly, through sexual contact or from mother to child during childbirth.

Globally, an estimated 58 million people are living with chronic Hepatitis C infection. The prevalence varies widely by region, with higher rates in parts of Africa, Central and East Asia, and Eastern Europe. In many high-income countries, the majority of new infections occur among people who inject drugs. Efforts to reduce transmission focus on harm reduction strategies, such as needle exchange programs and safe injection practices.

Hepatitis C Virus primarily targets liver cells, leading to inflammation and damage. The immune response to the virus can cause further liver injury. Over time, chronic infection can result in fibrosis (scarring) and cirrhosis, impairing liver function. The virus can also trigger immune-mediated conditions affecting other parts of the body, such as the skin, joints, and kidneys.

Preventing Hepatitis C involves reducing the risk of exposure to infected blood. Key strategies include using sterile needles and syringes, implementing safe injection practices, screening blood products, and promoting safe sex practices. There is currently no vaccine for Hepatitis C, making prevention efforts focused on reducing transmission risk crucial.

Hepatitis C is a viral infection that can lead to serious liver disease if left untreated. While many people may not experience symptoms, the virus can cause significant liver damage over time. Advances in antiviral treatments have greatly improved the outlook for those infected, offering the possibility of a cure. Prevention efforts focus on reducing exposure to infected blood, as there is no vaccine available.

If you suspect you may have been exposed to Hepatitis C or are experiencing symptoms such as fatigue, jaundice, or abdominal pain, it is important to get tested. Early diagnosis and treatment can prevent serious liver damage and improve health outcomes. Treatment is highly effective and can eliminate the virus from your body. Practicing safe injection and sexual practices can help prevent the spread of the virus.